Stay updated on Depemokimab in Severe Asthma Clinical Trial
Sign up to get notified when there's something new on the Depemokimab in Severe Asthma Clinical Trial page.

Latest updates to the Depemokimab in Severe Asthma Clinical Trial page
- Check4 days agoChange DetectedThe NIH transition notice about updated terminology and related FAQs was removed from the top of the page.SummaryDifference1%

- Check11 days agoChange DetectedThe ClinicalTrials.gov error page footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check25 days agoChange DetectedA site-wide NIH notice about the terminology transition from “artificial intelligence” to “super intelligence” appears above the error page. The site revision number changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check32 days agoChange DetectedThe site revision displayed in the footer changed from v3.7.0 to v3.7.1 while the page continued to show a 403 error.SummaryDifference0.2%

- Check53 days agoChange DetectedThe study record page now shows a 403 Forbidden error, replacing the expected study details. The page presents a minimal interface with a Home option, rather than the full study content and documents.SummaryDifference17%

- Check60 days agoChange DetectedA new Revision: v3.7.0 was added and the previous Revision: v3.6.6 was removed. This signifies an update to the page's versioning rather than content changes.SummaryDifference0.0%

Stay in the know with updates to Depemokimab in Severe Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Depemokimab in Severe Asthma Clinical Trial page.